Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody-Drug Conjugates with Self-Immolative Disulfide Linkers

被引:53
|
作者
Pillow, Thomas H. [1 ]
Schutten, Melissa [1 ]
Yu, Shang-Fan [1 ]
Ohri, Rachana [1 ]
Sadowsky, Jack [1 ]
Poon, Kirsten Achilles [1 ,4 ]
Solis, Willy [1 ,5 ]
Zhong, Fiona [1 ]
Del Rosario, Geoffrey [1 ]
Go, Mary Ann T. [1 ]
Lau, Jeffrey [1 ]
Yee, Sharon [1 ]
He, Jintang [1 ]
Liu, Luna [1 ]
Ng, Carl [1 ]
Xu, Keyang [1 ]
Leipold, Douglas D. [1 ]
Kamath, Amrita V. [1 ]
Zhang, Donglu [1 ]
Masterson, Luke [2 ]
Gregson, Stephen J. [2 ]
Howard, Philip W. [2 ]
Fang, Fan [3 ]
Chen, Jinhua [3 ]
Gunzner-Toste, Janet [1 ]
Kozak, Katherine K. [1 ]
Spencer, Susan [1 ]
Polakis, Paul [1 ]
Polson, Andrew G. [1 ]
Flygare, John A. [1 ]
Junutula, Jagath R. [1 ,6 ]
机构
[1] Genentech Inc, San Francisco, CA 94030 USA
[2] Spirogen Ltd, QMBInnovat Ctr, London, England
[3] WuXi AppTec Co Ltd, Shanghai, Peoples R China
[4] Denali Therapeut, San Francisco, CA USA
[5] Bristol Myers Squibb, Princeton, NJ USA
[6] Cellerant Therapeut, San Carlos, CA USA
关键词
BIOLOGICAL EVALUATION; TARGETED TREATMENT; CANCER-THERAPY; IN-VIVO; DESIGN; CHEMISTRY; SELECTION; STABILITY; LYMPHOMA; DELIVERY;
D O I
10.1158/1535-7163.MCT-16-0641
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A novel disulfide linker was designed to enable a direct connection between cytotoxic pyrrolobenzodiazepine (PBD) drugs and the cysteine on a targeting antibody for use in antibody-drug conjugates (ADCs). ADCs composed of a cysteine-engineered antibody were armed with a PBD using a self-immolative disulfide linker. Both the chemical linker and the antibody site were optimized for this new bioconjugation strategy to provide a highly stable and efficacious ADC. This novel disulfide ADC was compared with a conjugate containing the same PBD drug, but attached to the antibody via a peptide linker. Both ADCs had similar efficacy in mice bearing human tumor xenografts. Safety studies in rats revealed that the disulfide-linked ADC had a higher MTD than the peptide-linked ADC. Overall, these data suggest that the novel self-immolative disulfide linker represents a valuable way to construct ADCs with equivalent efficacy and improved safety. (C) 2017 AACR.
引用
收藏
页码:871 / 878
页数:8
相关论文
共 50 条
  • [41] Synthesis and evaluation of pyrrolobenzodiazepine dimer antibody-drug conjugates with dual β-glucuronide and dipeptide triggers
    Gregson, Stephen J.
    Barrett, Allison M.
    Patel, Neki V.
    Kang, Gyoung-Dong
    Schiavone, Davide
    Sult, Erin
    Barry, Conor S.
    Vijayakrishnan, Balakumar
    Adams, Lauren R.
    Masterson, Luke A.
    D'Hooge, Francois
    Snaith, Mike
    Harper, Jay
    Hartley, John A.
    Howard, Philip W.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 179 : 591 - 607
  • [42] Pharmacokinetics and toxicity considerations for antibody-drug conjugates: an overview
    Hejmady, Siddhanth
    Pradhan, Rajesh
    Kumari, Shobha
    Pandey, Meghna
    Dubey, Sunil K.
    Taliyan, Rajeev
    BIOANALYSIS, 2023, 15 (19) : 1193 - 1202
  • [43] Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
    Ben-Quan Shen
    Keyang Xu
    Luna Liu
    Helga Raab
    Sunil Bhakta
    Margaret Kenrick
    Kathryn L Parsons-Reponte
    Janet Tien
    Shang-Fan Yu
    Elaine Mai
    Dongwei Li
    Jay Tibbitts
    Jakub Baudys
    Ola M Saad
    Suzie J Scales
    Paul J McDonald
    Philip E Hass
    Charles Eigenbrot
    Trung Nguyen
    Willy A Solis
    Reina N Fuji
    Kelly M Flagella
    Darshana Patel
    Susan D Spencer
    Leslie A Khawli
    Allen Ebens
    Wai Lee Wong
    Richard Vandlen
    Surinder Kaur
    Mark X Sliwkowski
    Richard H Scheller
    Paul Polakis
    Jagath R Junutula
    Nature Biotechnology, 2012, 30 : 184 - 189
  • [44] Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
    Shen, Ben-Quan
    Xu, Keyang
    Liu, Luna
    Raab, Helga
    Bhakta, Sunil
    Kenrick, Margaret
    Parsons-Reponte, Kathryn L.
    Tien, Janet
    Yu, Shang-Fan
    Mai, Elaine
    Li, Dongwei
    Tibbitts, Jay
    Baudys, Jakub
    Saadi, Ola M.
    Scales, Suzie J.
    McDonald, Paul J.
    Hass, Philip E.
    Eigenbrot, Charles
    Trung Nguyen
    Solis, Willy A.
    Fuji, Reina N.
    Flagella, Kelly M.
    Patel, Darshana
    Spencer, Susan D.
    Khawlil, Leslie A.
    Ebens, Allen
    Wong, Wai Lee
    Vandlen, Richard
    Kaur, Surinder
    Sliwkowski, Mark X.
    Scheller, Richard H.
    Polakis, Paul
    Junutula, Jagath R.
    NATURE BIOTECHNOLOGY, 2012, 30 (02) : 184 - 189
  • [45] A Patent Review on FDA-Approved Antibody-Drug Conjugates, Their Linkers and Drug Payloads
    Chia, C. S. Brian
    CHEMMEDCHEM, 2022, 17 (11)
  • [46] Preparation and Assessment of Self-Immolative Linkers for Therapeutic Bioconjugates with Amino- and Hydroxyl-Containing Cargoes
    Sengee, Myagmarsuren
    Eksteen, J. Johannes
    Nergard, Silje Lillemark
    Vasskog, Terje
    Sydnes, Leiv K.
    BIOCONJUGATE CHEMISTRY, 2019, 30 (05) : 1489 - 1499
  • [47] Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates
    Schuster, Sabine
    Juhasz, Eva
    Halmos, Gabor
    Neundorf, Ines
    Gennari, Cesare
    Mezo, Gabor
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [48] Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates
    Tedeschini, T.
    Campara, B.
    Grigoletto, A.
    Bellini, M.
    Salvalaio, M.
    Matsuno, Y.
    Suzuki, A.
    Yoshioka, H.
    Pasut, G.
    JOURNAL OF CONTROLLED RELEASE, 2021, 337 : 431 - 447
  • [49] Bis(vinylsulfonyl)piperazines as efficient linkers for highly homogeneous antibody-drug conjugates
    Huang, Rong
    Sheng, Yao
    Wei, Ding
    Yu, Jianghui
    Chen, Hongli
    Jiang, Biao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 190
  • [50] Branched Linkers for Homogeneous Antibody-Drug Conjugates: How Long Is Long Enough?
    Gulyak, Evgeny L.
    Komarova, Olga A.
    Prokopenko, Yury A.
    Faizullina, Elina A.
    Malabuiok, Diana M.
    Ibragimova, Aigul R.
    Mokrushina, Yuliana A.
    Serova, Oxana V.
    Popova, Galina P.
    Zhitlov, Mikhail Y.
    Nikitin, Timofei D.
    Brylev, Vladimir A.
    Ustinov, Alexey V.
    Alferova, Vera A.
    Korshun, Vladimir A.
    Smirnov, Ivan V.
    Terekhov, Stanislav S.
    Sapozhnikova, Ksenia A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (24)